Health & Medicine

From empowering patients to rethinking how doctors and AI work together, Stanford’s weeklong symposium surfaced the ideas most likely to shape medicine’s next chapter.

In a small pilot study, a Stanford Medicine-developed tool showed promise by decreasing physician burnout while maintaining safety.

Stanford Medicine’s new proton therapy facility is ready for patients. On June 4 a child with a rare brain tumor became the first to receive treatment.

A Stanford team used geospatial data and detection algorithms to achieve a tenfold increase in rescues from modern slavery in the Brazilian Amazon. Now they’re planning to expand their approach.

Research shows that obexelimab halves relapse risk in patients with IgG4-related disease, a chronic immune condition often misdiagnosed as cancer.

Two existing drugs improve mucus clearance in animal models of cystic fibrosis, indicating a potential pathway to reduce chronic lung infections in humans.

The discovery that hormonal triggers cause “ruptoblast” cells in flatworms to detonate and destroy surrounding cells within minutes could inspire new ideas in medical science.

Many taking GLP-1 medications lose muscle as they shed fat. A study in mice suggests an existing drug could aid in muscle regeneration without affecting weight loss.

Stanford Medicine experts explain why it’s harder than ever to focus – and what we can do to block out distractions that often cloud our attention and memory.

Cy Chittenden biked 2,850 miles across America. His DNA is part of a Stanford study investigating the genetics of elite athlete endurance to inform longevity research and treatment strategies.